Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Slow progress, pipeline uncertainty & lack of catalysts weigh despite strong cash. Click to read why KYMR stock is a Hold.

Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...

The firm's analysts think highly of Target's long-term prospects, despite cutting their price target for the fifth time since ...

BMO Capital cut Terns Pharmaceuticals' price target from $26 to $15, citing costlier capital conditions despite maintaining ...

Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to ...

Nissan Motor unveiled sweeping new cost cuts, saying it would eliminate 11,000 more jobs and close 7 plants, capping a ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Global pharmaceutical company Pfizer (NYSE:PFE) in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The ...

The company held firm with its full-year profit growth outlook, as the impact of tariffs is expected to be limited. Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and is ...

Royal Caribbean Group reported first-quarter earnings that rose above expectations, and was one of the rare companies to raise their full-year outlook in the face of “heightened” uncertainties ...